Clinicopathologic Characteristics and Management of Infective Liver Collections in South Africa von Omoshoro-Jones, J.A.O., Pillay, K., Khan, Z.A., Nweke, E.E., Smith, M.D.

Volltext

Mass Spectrometry-based Analysis Demonstrates Proteomics Signatures Associated with Tumour Progression in South African Pancreatic Ductal Adenocarcinoma Patients von Nweke, E.E., Buthelezi, S., Dubazana, S., Elebo, N., Devar, J., Omoshoro-Jones, J., Smith, M.

Volltext

Creatine levels correlate with severity in a South African Pancreatic Ductal Adenocarcinoma Cohort von Elebo, N., Omoshoro-Jones, J., Abdel-Shafy, E.A., Devar, J., Smith, M., Fru, P., Cacciatore, S., Nweke, E.E.

Volltext

SPP-1 is Overexpressed in Resected Pancreatic Ductal Adenocarcinoma (PDAC) Tumours von Mhlambi, N.H.M., Nsingwane, Z., Candy, G., Devar, J., Omoshoro-Jones, J., Smith, M., Nweke, E.E.

Volltext

Proteome Analysis Distinguishes Gallbladder Cancer from Gallstone Disease in Patients of African Ancestry von Baichan, P., Naicker, P., Devar, J., Smith, M., Candy, G., Nweke, E.E.

Volltext

Complement Protein Levels Decrease with Tumour Severity in Pancreatic Ductal Adenocarcinoma von Nsingwane, Z., Elebo, N., Mhlambi, N., Devar, J., Omoshoro-jones, J., Smith, M., Candy, G., Nweke, E.E.

Volltext

Proteogenomic analysis demonstrates novel potential targets of pancreatic ductal adenocarcinoma in African patients von Nweke, E.E., Naicker, P., Aaron, S., Stoychev, S., Devar, J., Tabb, D., Omoshoro-Jones, J., Smith, M., Candy, G.

Volltext

Metabolic profiling of a cohort of pancreatic ductal adenocarcinoma (PDAC) patients of african ancestry von ELebo, N., Cacciatore, S., Fru, P., Omoshoro-Jones, J., Zerbini, L., Devar, J., Smith, M., Candy, G., Nweke, E.E.

Volltext

Metabolites Levels Correlate to Tumour Stage and Survival in Pancreatic Ductal Adenocarcinoma Patients von Elebo, N., Omoshoro-Jones, J., Fru, P., De Wet van Zyl, C., Vorster, C., Smith, M., Cacciatore, S., Candy, G., Nweke, E.E.

Volltext

Quantitative proteonomics confirms microRNA targets in pancreas cancer to explain why cetuximab has limited efficacy in prolonging patient survival von Brand, M., Nweke, E.E., Zhou, L., He, C., Majole, M., Candy, G.

Volltext

Quantitative proteonomics confirms microRNA targets in pancreas cancer to explain why cetuximab has limited efficacy in prolonging patient survival von Brand, M., Nweke, E.E., Zhou, L., He, C., Majole, M., Candy, G.

Volltext